Document is current
Any future updates will be listed below
-
Authors
Hachisuka, Ayaka https://orcid.org/0000-0002-7095-856X
Shor, Jonathan D. https://orcid.org/0000-0002-0803-4155
Liu, Xujin Chris
Friedman, Daniel
Dugan, Patricia
Saez, Ignacio https://orcid.org/0000-0003-0651-2069
Panov, Fedor E.
Wang, Yao https://orcid.org/0000-0003-3199-3802
Doyle, Werner
Devinsky, Orrin https://orcid.org/0000-0003-0044-4632
Oermann, Eric K. https://orcid.org/0000-0002-1876-5963
He, Biyu J. https://orcid.org/0000-0003-1549-1351
-
Funding
Funding for this research was provided by:
W. M. Keck Foundation
National Science Foundation (BCS-1926780)
- License Information
-
More Information
Article History
Received: 6 September 2024
Accepted: 7 January 2026
First Online: 4 February 2026
Competing interests
: E.K.O. reports equity in Artisight Inc., Delvi Inc., and Eikon Therapeutics. E.K.O. has consulting arrangements with Google Inc., and Sofinnova Partners. The remaining authors declare no competing interests.
